(Date:7/24/2008).../PRNewswire-FirstCall/ -- The board of,directors f...he repurchase of,up to $100 million of the company...de from time to time in the open market or in priv...from the company,s available,cash and cash flow., ...hase program for our,new company reflects its conf...
(Date:7/24/2008)...fers Free Diabetes Education and Cholesterol ...IANAPOLIS, Ind., July 24 /PRNewswire-FirstCall/ --...acing and Polymer Technology Systems,Inc. as a pa...ness Tour to,provide free diabetes educational inf...IndyCar Series during the 2008 racing season., El...
(Date:7/24/2008)...al,s companionship can be significant, experts say... -- When the elderly woman first arrived at Brooke...me of the staffers were skeptical when they saw sh...e early stages of dementia, "floated in and out," ...ministrator at Brooke Grove, a center specializing...
(Date:7/24/2008)...wswire/ -- New research from the Journal of,the Am...IV/AIDS will be,released to the media, coinciding ...e world,s top HIV/AIDS researchers will present th...s, mitigating drug side effects and,assessing surv...oed until,10 a.m. (CT) Sun., Aug. 3, 2008., Wha...
Breaking Medicine News(10 mins):Health News:Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program 2Health News:Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country 2Health News:Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country 3Health News:Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country 4Health News:Pet Doors Opening at Assisted Living Centers 2Health News:Pet Doors Opening at Assisted Living Centers 3
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial.
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium.
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor.
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum.
Medicine Products:(Date:7/23/2008)...stemic Therapy to Treat the Disease -, WAYNE, N.J...tCall/ --,Bayer HealthCare Pharmaceuticals and Ony...nced that The New England Journal of Medicine publ...t Nexavar(R) (sorafenib),tablets decreased the abs...,unresectable hepatocellular carcinoma (HCC), or l...
(Date:7/23/2008)...- FluoroPharma Inc., a company developing,breakthr...ssion Tomography,(PET) market, announced positive ...abeled tracer for myocardial perfusion imaging. BF...t to complete Phase I clinical,development., BFPE...lood flow in the,heart (myocardial perfusion). Myo...
(Date:7/23/2008)...g Work with Protein Therapeutics that Mo...CAMBRIDGE, Mass., July 23 /- Taligen ... a corporate growth plan with the,appointment of A...nd the,establishment of its headquarters in Cambri....D., a co-founder of the company who remains presi...
(Date:7/22/2008)...cs Development Initiative bring MJFF,s,current act...anuary 20,2009, NEW YORK, July 22 /PRNewswire-US...ery of transformative treatments and a cure for Pa...or Parkinson,s Research has awarded,$2.7 million i...e awards,were granted under MJFF,s Therapeutics De...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Studies lend insights into colorectal cancer screening 2443 1Studies lend insights into colorectal cancer screening 2443 2Studies lend insights into colorectal cancer screening 2443 3New technology identifies warped fingerprints at warp speed 617 1New technology identifies warped fingerprints at warp speed 617 2Kids TV Viewing Tied to Behavioral Problems 2435 1Kids TV Viewing Tied to Behavioral Problems 2435 2Kids TV Viewing Tied to Behavioral Problems 2435 3Women with severe PMS perceive their sleep quality to be poor 2431 1Women with severe PMS perceive their sleep quality to be poor 2431 2... -- New Preclinical Information May Correlate with...ISA and MERLIN TIMI-36 Clinical,Trials --, PALO AL... CV,Therapeutics, Inc. announced today that resear...es showing that ranolazine increased,glucose stimu...In,separate experiments using preclinical models o...
... SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- Por...e II data on its lead,compound, PRT054021, an oral... the International Society on Thrombosis and Haemo...rial showed that,PRT054021 was safe, effective, an...mboembolic events (VTE) in patients,undergoing tot...
Other Medicine Technology:CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of,Action for Ranexa 2CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of,Action for Ranexa 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4